TrialActa dermato-venereologica2022

Dupilumab Provides Rapid and Sustained Improvement in SCORing Atopic Dermatitis Outcomes in Paediatric Patients with Atopic Dermatitis.

Andreas Wollenberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.